WiFi equipment maker Ruckus Wireless has set an initial public offering range of $13 per share to $15 per share and expects to sell 8.4m shares of stock.

Wintech owned a 7.3% stake, or 1.5 million shares, ahead of the flotation, which went down to 4.8% post the IPO.

Regulus Therapeutics has raised $80.9m in total proceeds from its initial public offering, a private placement, and convertible note.

Shareholders in Lifelock include American global computer security software corporation Symantec Corp (8.2%) and investment banking firm Goldman Sachs (10.9%) as well as venture firms Bessemer Venture Partners, Kleiner Perkins Caufield & Byers and Industry Ventures.

Other stockholders in the US-based antibody research company backed by Mitsubishi, include MPM BioVentures (17.72%), Sofinnova Ventures (11.86%), Alloy Ventures (11.19%), and Fidelity Ventures (9.71%).

Motorola and Deutsche Telekom-backed WiFi products manufacturer Ruckus Wireless files for flotation after raising $54.2m in its history.

Celgene-backed GlobeImmune's flotation is still pending, as of this article, having been reportedly delayed last week.

Shareholders in the semiconductor manufacturer include Intel, Morgenthaler Partners, Canaan Partners, Institutional Venture Partners, DCM, El Dorado Ventures, and Kodiak Venture Partners.